4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0001209191-23-056987
Chief Executive Officer gave up 43,443 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tak Paul Peter Chief Executive Officer | 2023-11-28 | Shares withheld for taxes | −43,443 | $0.90 | $39,099 | 373,556 | D |
Loading xslF345X05/doc4.xml…